SCHEMBL1142269

SCHEMBL1142269

C=C(CCCCCCCCCCC)OCC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.45
FAAH O00519 2/20 0.43
TSHR P16473 5/20 0.42
CES2 O00748 3/20 0.42
CES1 P23141 3/20 0.42
GPR84 Q9NQS5 7/20 0.41
PPARG P37231 6/20 0.41
PPARD Q03181 6/20 0.41
PPARA Q07869 6/20 0.41
HDAC11 Q96DB2 5/20 0.41
ALDH1A1 P00352 2/20 0.41
TLR2 O60603 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
FABP4 P15090 2/20 0.41
PTPN1 P18031 2/20 0.41
SLC22A6 Q4U2R8 1/20 0.41
SLC22A8 Q8TCC7 1/20 0.41
MEN1 O00255 1/20 0.41
ESR1 P03372 1/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1142873 1.00 DGKA (0.45) DGKAFAAHTSHRCES2CES1
SCHEMBL8997400 1.00 DGKA (0.45) DGKAFAAHTSHRCES2CES1
SCHEMBL1734339 1.00 DGKA (0.45) DGKAFAAHTSHRCES2CES1
SCHEMBL1142623 1.00 DGKA (0.45) DGKAFAAHTSHRCES2CES1
SCHEMBL1142335 1.00 DGKA (0.45) DGKAFAAHTSHRCES2CES1
SCHEMBL12189736 1.00 DGKA (0.45) DGKAFAAHTSHRCES2CES1
SCHEMBL5164923 0.90
SCHEMBL4966305 0.90
SCHEMBL31570139 0.84 FAAH (0.33) DGKAFAAHTSHRCES2CES1
SCHEMBL1142604 0.84 TSHR (0.48) DGKATSHRCES2CES1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110035995-A1 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS BUSCH RAINER 2011-02-17 US claimed
EP-2201156-A2 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS Busch, Rainer (US) 2010-06-30 EP claimed
WO-2009035689-A2 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS BUSCH RAINER (US) 2009-03-19 WO claimed
EP-2201156-B1 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS BUSCH RAINER (US) 2013-10-02 EP disclosed
US-8444845-B2 Biofuel composition and manufacturing process BUSCH RAINER (US) 2013-05-21 US disclosed
US-20110035995-A1 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS BUSCH RAINER 2011-02-17 US disclosed
EP-2201156-A2 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS Busch, Rainer (US) 2010-06-30 EP disclosed
WO-2009035689-A2 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS BUSCH RAINER (US) 2009-03-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110035995-A1 BIOFUEL COMPOSITION AND MANUFACTURING PROCESS FASN, SCD, ADH1A DGKA 86/4885FAAH 163/4885TSHR 4062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.